Danielle Castillo

Significant clinical impact of recurrent <i>BRCA1</i> and <i>BRCA2</i> mutations in Mexico

Cynthia Villarreal‐Garza, Rosa María Álvarez-Gómez, Carlos Pérez‐Plasencia et al. · Cancer · 2014 · 96 citations · Full text

Life Sciences, Genetics, Molecular Genetics +17

BRCA2 Polymorphic Stop Codon K3326X and the Risk of Breast, Prostate, and Ovarian Cancers

Huong Meeks, Honglin Song, Kyriaki Michailidou et al. · JNCI Journal of the National Cancer Institute · 2015 · 92 citations · Full text

Medicine, Genetics, Molecular Genetics +16

The prevalence of BRCA1 and BRCA2 mutations among young Mexican women with triple-negative breast cancer

Cynthia Villarreal‐Garza, Jeffrey N. Weitzel, M Llacuachaqui et al. · Breast Cancer Research and Treatment · 2015 · 86 citations · Full text

Medicine, Genetics, Oncology +16

Prospective Study of Cancer Genetic Variants: Variation in Rate of Reclassification by Ancestry

Thomas P. Slavin, Lily R. Van Tongeren, Carolyn E. Behrendt et al. · JNCI Journal of the National Cancer Institute · 2018 · 71 citations · Full text

Life Sciences, Genetics, Oncology +17

Pathogenic and likely pathogenic variants in <i>PALB2</i> , <i>CHEK2</i> , and other known breast cancer susceptibility genes among 1054 <i>BRCA</i> ‐negative Hispanics with breast cancer

Jeffrey N. Weitzel, Susan L. Neuhausen, Aaron W. Adamson et al. · Cancer · 2019 · 63 citations · Full text

Life Sciences, Genetics, Molecular Genetics +17